查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1370972

消费者保健市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按类型（非处方药、膳食补充剂）、按应用（零售、线上、医院）、按地区和竞争细分

Consumer Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (OTC Pharmaceuticals, Dietary Supplements), By Application (Retail, Online, Hospitals), By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 170 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球消费者医疗保健市场价值为 3,447 亿美元，预计在整个预测期内将出现强劲增长，年复合成长率(CAGR) 为 8.14%，预计到 2028 年将达到 5,519.1 亿美元。消费者医疗保健包括与健康、口腔健康、营养和皮肤健康相关的一系列产品。该部门主要由非处方药 (OTC) 组成，包括药品、维生素和矿物质补充剂，无需处方即可直接销售给消费者。非处方药的例子包括牙膏、漱口水、某些眼药水、除疣剂、含抗生素的急救霜和去屑洗髮精。这些产品受到各国监管机构的监管，以确保在没有医生监督的情况下使用时的安全性和可靠性。

主要市场驱动因素

提高对生活方式疾病的认识

市场概况
预测期 2024-2028
2022 年市场规模 3,447亿美元
2028 年市场规模 5519.1亿美元
2023-2028 年CAGR 8.14%
成长最快的细分市场 非处方药
最大的市场 北美洲

对生活方式疾病的认识不断提高是市场成长的重要动力。都市化和消费主义导致饮食习惯和生活方式的转变，导致人工和合成食品的消费增加。因此，由于久坐的生活方式和饮食不均衡，心臟病、肥胖、糖尿病和动脉粥状硬化等生活方式疾病的盛行率上升。消费者越来越意识到这些影响，导致人们开始购买膳食补充品、运动营养品和体重管理产品。这一趋势正在推动消费者保健市场的成长，新的参与者进入市场，在过敏缓解、消化健康、女性护理、疼痛缓解和膳食补充剂等领域提供增值产品。

远距医疗和远距医疗的快速采用

COVID-19 大流行加速了远距医疗和远距医疗在全球的采用，对消费者医疗保健市场产生了重大影响。患者已转向虚拟医疗保健解决方案，为消费者医疗保健产品分销商创造了根据患者需求客製化产品的机会。这一趋势正在促进消费者保健产品的创新并推动市场成长。

以患者为中心的治疗的需求不断增加

以患者为中心的护理趋势使个人能够在管理自己的健康方面发挥积极作用，这正在推动对个人化医疗保健解决方案的需求。患者正在寻求适合其健康目标和状况的产品和服务，导致对健康和保健产品的需求激增，包括维生素、补充剂、健身器材、健康食品和替代疗法。这一趋势与数位健康工具和穿戴式装置的使用相一致，这些工具和穿戴式装置使患者能够即时监控自己的健康指标。

老年人口增加

不断增加的老年人口正在增加对消费者保健产品和服务的需求。老年人通常需要与健康相关的产品和服务来满足他们独特的健康挑战。老年人经常患有慢性健康问题，导致对药物、监测设备和生活方式管理工具等消费者保健产品的需求。老年人对维生素、补充剂和健康服务等预防保健产品的需求也在上升。

主要市场挑战

假药的盛行

假药的存在给消费者医疗保健产业带来了重大挑战。假冒药物经常扭曲其来源、合法性或功效，危害公众健康。这些产品可能含有不足或不含活性成分，导致治疗失败或不良反应。打击假药对于确保消费者安全和市场成长至关重要。

低度开发地区的挑战

在低度开发地区，扩大消费者医疗保健市场面临挑战，这些地区的医疗保健基础设施不足、经济疲软和意识有限，阻碍了产品和服务的分销。缺乏数位解决方案以及对新产品的怀疑进一步阻碍了这些领域的市场成长。

主要市场趋势

加速线上资源的使用

消费者医疗保健行业线上资源的使用增加是一个突出趋势。线上平台提供健康相关讯息，支持使用非处方药进行自我治疗。消费者保健公司正在利用线上平台进行行销和销售，扩大电子商务管道，并满足对健康相关内容和产品不断增长的需求。

自我治疗的倾向不断上升

自我药疗的趋势正在推动消费者保健产品的需求。消费者正在积极利用非处方药、补充剂和健康相关应用程式解决轻微的健康问题。这一趋势正在影响产品开发并增加对一系列医疗保健解决方案的需求。

细分市场洞察

类型 段

市场分为非处方药品和膳食补充剂。非处方药因其治疗常见疾病的安全性和有效性而在市场上占据主导地位。然而，随着消费者寻求个人化的健康解决方案，包括维生素和矿物质在内的膳食补充剂预计将经历最高的成长率。

最终用户部分

零售是最大的部分，包括零售药局和有组织/无组织的零售店。由于网路普及率的提高和人们对网上购物好处的认识不断提高，网路零售预计将快速增长。

区域洞察

在主要製药公司和高效分销管道的推动下，北美引领市场。欧洲紧随其后，对天然成分和预防性医疗保健的需求不断增长。亚太地区也在经历成长，特别是由于意识和网路普及率的提高。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球消费者保健市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型（非处方药、膳食补充剂）
    • 按应用（零售、线上、医院）
    • 按地区
    • 按公司划分 (2022)
  • 市场地图

第 6 章：北美消费者医疗保健市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按应用
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲消费者保健市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按应用
    • 按国家/地区
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第 8 章：亚太消费保健市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按应用
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第 9 章：南美洲消费者保健市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按应用
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲消费保健市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按应用
    • 按国家/地区
  • MEA：国家分析
    • 南非消费者医疗保健
    • 沙乌地阿拉伯消费者保健
    • 阿联酋消费者医疗保健

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：全球口腔临床营养市场：SWOT 分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 服务内容
  • 最近的发展
  • 主要人员
  • SWOT分析
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Limited
    • Johnson & Johnson
    • GlaxoSmithKline plc
    • Sanofi SA
    • Amway Corp.
    • Bayer AG
    • BASF SE
    • Abbott Laboratories
    • Boehringer Ingelheim International Gmbh

第 16 章：策略建议

第 17 章：关于我们与免责声明

简介目录
Product Code: 4680

Global Consumer Healthcare Market was valued at USD 344.70 billion, and it is anticipated to experience strong growth throughout the forecast period, with a Compound Annual Growth Rate (CAGR) of 8.14% and expected to reach USD 551.91 Billion through 2028. Consumer healthcare encompasses a range of products related to wellness, oral health, nutrition, and skin health. This sector primarily consists of over-the-counter (OTC) drugs, including medicines, vitamins, and mineral supplements that are sold directly to consumers without a prescription. Examples of OTC drugs include toothpaste, mouthwashes, certain eye drops, wart removers, first aid creams with antibiotics, and dandruff shampoos. These products are regulated by various countries' regulatory agencies to ensure their safety and reliability when used without physician supervision.

Key Market Drivers

Increasing Awareness of Lifestyle Diseases

Market Overview
Forecast Period2024-2028
Market Size 2022USD 344.70 Billion
Market Size 2028USD 551.91 Billion
CAGR 2023-20288.14%
Fastest Growing SegmentOTC Pharmaceuticals
Largest MarketNorth America

The rising awareness of lifestyle diseases is a significant driver of market growth. Urbanization and consumerism have led to shifts in dietary habits and lifestyles, resulting in an increase in the consumption of artificial and synthetic food products. Consequently, the prevalence of lifestyle diseases such as heart disease, obesity, diabetes, and atherosclerosis has risen due to sedentary lifestyles and imbalanced diets. Consumers are becoming more aware of these implications, leading to an uptake in dietary supplements, sports nutrition, and weight management products. This trend is driving the consumer healthcare market's growth, with new players entering the market to offer value-added products in segments such as allergy relief, digestive health, feminine care, pain relief, and dietary supplements.

Rapid Adoption of Telehealth and Telemedicine

The global adoption of telehealth and telemedicine, accelerated by the COVID-19 pandemic, has significantly impacted the consumer healthcare market. Patients have turned to virtual healthcare solutions, creating opportunities for consumer healthcare product distributors to tailor their offerings to patients' needs. This trend is fostering innovation in consumer healthcare products and driving market growth.

Increasing Demand for Patient-Centric Treatments

The trend toward patient-centric care, which empowers individuals to take an active role in managing their health, is driving the demand for personalized healthcare solutions. Patients are seeking products and services tailored to their health goals and conditions, leading to a surge in demand for health and wellness products, including vitamins, supplements, fitness equipment, healthy foods, and alternative therapies. This trend aligns with the use of digital health tools and wearables that allow patients to monitor their health metrics in real time.

Rising Geriatric Population

The increasing geriatric population is boosting the demand for consumer healthcare products and services. Older adults often require health-related products and services that cater to their unique health challenges. Geriatric individuals frequently have chronic health conditions, leading to a demand for consumer healthcare products like medications, monitoring devices, and lifestyle management tools. The demand for preventive healthcare products such as vitamins, supplements, and wellness services is also rising among older adults.

Key Market Challenges

Prevalence of Counterfeit Pharmaceuticals

The presence of counterfeit pharmaceuticals poses a significant challenge to the consumer healthcare industry. Counterfeit medications often misrepresent their origin, legitimacy, or efficacy, jeopardizing public health. These products may contain insufficient or no active ingredients, leading to treatment failure or adverse effects. Combatting counterfeit drugs is essential to ensure consumer safety and market growth.

Challenges in Underdeveloped Areas

Expanding the consumer healthcare market faces challenges in underdeveloped regions where inadequate healthcare infrastructure, weak economies, and limited awareness hinder the distribution of products and services. Lack of access to digital solutions and skepticism about new products further impede market growth in these areas.

Key Market Trends

Accelerated Use of Online Resources

The increased use of online resources in the consumer healthcare industry is a prominent trend. Online platforms provide health-related information, enabling self-medication with OTC medicines. Consumer healthcare companies are leveraging online platforms for marketing and sales, expanding e-commerce channels, and meeting the growing demand for health-related content and products.

Rising Inclination Towards Self-Medication

The trend toward self-medication is driving the demand for consumer healthcare products. Consumers are proactively addressing minor health issues with OTC medications, supplements, and health-related apps. This trend is influencing product development and increasing the demand for a range of healthcare solutions.

Segmental Insights

Type Segment

The market is divided into OTC Pharmaceuticals and Dietary Supplements. OTC pharmaceuticals dominate the market due to their safe and effective nature for treating common illnesses. However, Dietary Supplements, including vitamins and minerals, are projected to experience the highest growth rate as consumers seek personalized health solutions.

End User Segment

Retail is the largest segment, encompassing retail pharmacies and organized/unorganized retail stores. Online retail is expected to grow rapidly due to increasing internet penetration and awareness of online shopping benefits.

Regional Insights

North America leads the market, driven by major pharmaceutical companies and efficient distribution channels. Europe follows with growing demand for natural ingredients and preventive healthcare. The Asia Pacific region is also experiencing growth, particularly due to rising awareness and internet penetration.

Key Market Players

  • Pfizer Inc.
  • Teva Pharmaceutical Industries Limited
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Amway Corp.
  • Bayer AG
  • BASF SE
  • Abbott Laboratories
  • Boehringer Ingelheim International Gmbh

Report Scope:

In this report, the Global Consumer Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

Consumer Healthcare Market, By Type:

  • OTC Pharmaceuticals
  • Dietary Supplements

Consumer Healthcare Market, By Application:

  • Retail
  • Online
  • Hospitals

Consumer Healthcare Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Consumer Healthcare Market.

Available Customizations:

  • Global Consumer Healthcare market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Consumer Healthcare Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (OTC Pharmaceuticals, Dietary Supplements)
    • 5.2.2. By Application (Retail, Online, Hospitals)
    • 5.2.3. By Region
    • 5.2.4. By Company (2022)
  • 5.3. Market Map

6. North America Consumer Healthcare Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Consumer Healthcare Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Consumer Healthcare Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Consumer Healthcare Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Consumer Healthcare Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Consumer Healthcare Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Consumer Healthcare Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. Italy Consumer Healthcare Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. France Consumer Healthcare Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Consumer Healthcare Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia-Pacific Consumer Healthcare Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Consumer Healthcare Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Consumer Healthcare Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Consumer Healthcare Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Consumer Healthcare Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Consumer Healthcare Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. South America Consumer Healthcare Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Consumer Healthcare Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Consumer Healthcare Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Consumer Healthcare Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Consumer Healthcare Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Consumer Healthcare Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Consumer Healthcare Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Consumer Healthcare Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Oral Clinical Nutrition Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Pfizer Inc.
    • 15.5.2. Teva Pharmaceutical Industries Limited
    • 15.5.3. Johnson & Johnson
    • 15.5.4. GlaxoSmithKline plc
    • 15.5.5. Sanofi S.A.
    • 15.5.6. Amway Corp.
    • 15.5.7. Bayer AG
    • 15.5.8. BASF SE
    • 15.5.9. Abbott Laboratories
    • 15.5.10. Boehringer Ingelheim International Gmbh

16. Strategic Recommendations

17. About Us & Disclaimer